AstraZeneca PLC ADR (AZN) Social Stream
ASTRAZENECA PLC (AZN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AZN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 7 | $73 | $66 | $69.1 | $64.59 | 6.98% |
| 2021-12-07 | 7 | $73 | $66 | $69.1 | $64.59 | 6.98% |
| 2022-01-17 | 7 | $73 | $60 | $67.1 | $64.59 | 3.89% |
| 2022-02-02 | 7 | $73 | $62.5 | $67.725 | $64.59 | 4.85% |
| 2022-02-10 | 7 | $69.4 | $62.5 | $65.725 | $64.59 | 1.76% |
| 2022-02-23 | 7 | $69.4 | $59.5 | $64.975 | $64.59 | 0.6% |
| 2022-02-24 | 7 | $70 | $59.5 | $66.225 | $64.59 | 2.53% |
| 2022-04-06 | 6 | $70 | $59.5 | $66.225 | $64.59 | 2.53% |
| 2022-04-11 | 6 | $82 | $59.5 | $69.375 | $64.59 | 7.41% |
| 2022-04-28 | 5 | $80 | $62 | $70.35 | $64.59 | 8.92% |
| 2022-04-30 | 5 | $82 | $62 | $73.5 | $64.59 | 13.79% |
| 2022-05-03 | 5 | $80 | $62 | $74.25 | $64.59 | 14.96% |
| 2022-06-06 | 5 | $80 | $59 | $73.5 | $64.59 | 13.79% |
| 2022-08-13 | 6 | $80 | $58.5 | $73.375 | $64.59 | 13.6% |
| 2022-10-05 | 7 | $80 | $58.5 | $73.7 | $64.59 | 14.1% |
| 2022-10-28 | 7 | $80 | $54.5 | $72.9 | $64.59 | 12.87% |
| 2022-11-11 | 7 | $80 | $54.5 | $73.5 | $64.59 | 13.79% |
| 2022-12-03 | 7 | $80 | $54.5 | $73.7 | $64.59 | 14.1% |
| 2022-12-12 | 7 | $88 | $54.5 | $75.3 | $64.59 | 16.58% |
| 2023-01-04 | 8 | $88 | $64.5 | $77.3 | $64.59 | 19.68% |
| 2023-04-18 | 9 | $88 | $64.5 | $78.083 | $64.59 | 20.89% |
| 2023-04-27 | 9 | $88 | $67 | $78.5 | $64.59 | 21.54% |
| 2023-06-07 | 9 | $88 | $67 | $78.166 | $64.59 | 21.02% |
| 2023-06-15 | 9 | $88 | $67 | $79.166 | $64.59 | 22.57% |
| 2023-07-07 | 9 | $88 | $66.5 | $79.083 | $64.59 | 22.44% |
| 2023-08-01 | 10 | $88 | $66.5 | $79.083 | $64.59 | 22.44% |
| 2023-09-12 | 10 | $88 | $66.5 | $80.3 | $64.59 | 24.32% |
| 2023-11-09 | 10 | $88 | $78 | $83 | $64.59 | 28.5% |
| 2023-11-17 | 10 | $88 | $77 | $82.8 | $64.59 | 28.19% |
| 2023-11-27 | 10 | $88 | $77 | $82.5 | $64.59 | 27.73% |
The Trend in the Analyst Price Target
Over the past 23 months, AZN's average price target has gone up $15.4.
AZN reports an average of 14.26% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-09 | 8 | 88 | 64.5 | 78.083 | 67.42 | 15.82% |
| 2023-06-08 | 9 | 88 | 67.0 | 79.166 | 74.25 | 6.62% |
| 2023-06-15 | 9 | 88 | 67.0 | 79.166 | 74.62 | 6.09% |
| 2023-07-07 | 10 | 88 | 66.5 | 79.083 | 64.85 | 21.95% |
| 2023-08-01 | 10 | 88 | 66.5 | 80.300 | 71.45 | 12.39% |
AZN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 8 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
AZN's average broker recommendation rating improved by 0.37 over the prior 17 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of stocks in the mega market cap category, ASTRAZENECA PLC's number of analysts covering the stock is greater than 170.32% of them.
- AZN has a lower variance in analysts' estimates than -386.89% of Pharmaceutical Products stocks.
- ASTRAZENECA PLC's upside potential (average analyst target price relative to current price) is higher than 505.94% of Pharmaceutical Products stocks.
- ASTRAZENECA PLC's average analyst price target is greater than 2961.87% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ASTRAZENECA PLC are NVS, ABBV, and MRK.
View All Top Stocks by Price Target
Make investment decisions regarding AZN using the data that counts. Try POWR Ratings for free.